Emmaus Life Sciences Revenue and Competitors

Location

$99.2M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Emmaus Life Sciences's estimated annual revenue is currently $5.3M per year.(i)
  • Emmaus Life Sciences's estimated revenue per employee is $100,500
  • Emmaus Life Sciences's total funding is $99.2M.

Employee Data

  • Emmaus Life Sciences has 53 Employees.(i)
  • Emmaus Life Sciences grew their employee count by -2% last year.

Emmaus Life Sciences's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
SVP FinanceReveal Email/Phone
3
General CounselReveal Email/Phone
4
SVP Research and DevelopmentReveal Email/Phone
5
ControllerReveal Email/Phone
6
VP, Global MarketingReveal Email/Phone
7
Director Clinical Development and Medical AffairsReveal Email/Phone
8
Director, Clinical Development and Medical AffairsReveal Email/Phone
9
Chief Administrative OfficerReveal Email/Phone
10
Director, Clinical Development and Medical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Emmaus Life Sciences?

Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. We are initially focusing our product development efforts in Sickle Cell Disease, a genetic disorder. Our lead product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in our completed Phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.

keywords:N/A

$99.2M

Total Funding

53

Number of Employees

$5.3M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Emmaus Life Sciences News

2022-03-30 - Emmaus Life Sciences Reports 2021 Financial Results and ...

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. The company...

2022-03-30 - Emmaus Life Sciences Announces Endari® To Be Added to ...

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of...

2022-03-22 - Emmaus Life Sciences Receives UAE Marketing Authorization ...

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. The company...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.6M5326%N/A
#2
$12M5417%N/A
#3
$14.1M54-5%N/A
#4
$13.1M544%N/A
#5
$13.1M548%N/A